A case of Silver-Russell syndrome (SRS): Multiple pituitary hormone deficiency, lack of H19 hypomethylation and favourable growth hormone (GH) treatment response

Journal of Genetics

Volumn 88, Issue 2, 2009, Pages 239-243

  Gucev, Zoran S ^a   Tasic, Velibor ^a   Jancevska, Aleksandra ^a   Kirovski, Ilija ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Growth hormone treatment; Human genetics; Hypopituitarism; IGF2 H19 locus; Methylation status; Silver Russell syndrome

Indexed keywords

GROWTH HORMONE; PRIMER DNA; RNA H19; UNTRANSLATED RNA;

ARTICLE; CASE REPORT; DNA METHYLATION; GENETICS; HUMAN; INFANT; MALE; MULTIPLE MALFORMATION SYNDROME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SYNDROME;

ABNORMALITIES, MULTIPLE; BASE SEQUENCE; DNA METHYLATION; DNA PRIMERS; GROWTH HORMONE; HUMANS; INFANT; MALE; POLYMERASE CHAIN REACTION; RNA, UNTRANSLATED; SYNDROME;

EID: 70350787154     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-009-0033-y     Document Type: Article

References (41)

1. Abu-Amero S., Monk D., Frost J., Preece M., Stanier P. and Moore G. E. 2008 The genetic aetiology of Silver-Russell syndrome. J. Med. Genet. 45, 193-199.
2. Albertsson-Wikland K. 1989 Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Swedish paediatric study group for growth hormone treatment. Acta Paediatr. Scand. Suppl. 349, 35-41.
3. Azcona C., Albanese A., Bareille P. and Stanhope R. 1998 Growth hormone treatment in growth hormone-sufficient and - insufficient children with intrauterine growth retardation/Russell-Silver syndrome. Horm. Res. 50, 22-27.
4. Binder G., Seidel A. K., Weber K., Haase M., Wollmann H. A., Ranke M. B. et al. 2006 IGF-II Serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the igf2 locus. J. Clin. Endocrinol. Metabol. 91, 4709-4712.
5. Binder G., Seidel A. K., Martin D. D., Schweizer R., Schwarze C. P., Wollmann H. A. et al. 2008 The endocrine phenotype in Silver-Russell syndrome is defined by the underlying epigenetic alteration. J. Clin. Endocrinol. Metab. 93, 1402-1407.
6. Bliek J., Terhal P., van den Bogaard M. J., Maas S., Hamel B., Salieb-Beugelaar G. et al. 2006 Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am. J. Hum. Genet. 78, 604-614.
7. Boguszewski M., Rosberg S. and Albertsson-Wikland K. 1995 Spontaneous growth hormone profiles in prepubertal small for gestational age children with short stature and intrauterine growth retardation. Horm. Res. 80, 2599-2606.
8. Cassidy S. B., Blonder O., Courtney V. W., Ratzan S. K. and Carey D. E. 1986 Russell-Silver syndrome and hypopituitarism. Patient report and literature review. Am. J. Dis. Child. 140, 155-159.
9. Chatelain P. G. 1993 Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: analysis of data from the Kabi pharmacia international growth study. International board of the Kabi pharmacia international growth study. Acta Paediatr. Suppl. 82,(suppl. 391) 79-81.
10. Chitayat D., Friedman J. M., Anderson L. and Dimmick J. E. 1988 Hepatocellular carcinoma in a child with familial Russell-Silver syndrome. Am. J. Med. Genet. 31, 909-914.
11. Dang Y. N., Shin I. C., Gordon R. A. and Karcioglu Z. A. 2004 Bilateral reactive lymphoid hyperplasia of the orbit in a child with Russell-Silver syndrome. J. AAPOS8, 588-591.
12. de Onis M., Onyango A. W., Borghi E., Siyam A., Nishida C. and Siekmann J. 2007 Development of a WHO growth reference for school-aged children and adolescents. Bull. W. H. O. 85, 660-667.
13. Eeckels R., van der Schueren-Lodeweyckx M. and Wolter R. 1970 Plasma growth hormone determination in the Silver-Russel syndrome. Helv. Paediatr. Acta25, 363-370.
14. Eggermann T., Eggermann K., Mergenthaler S., Kuner R., Kaiser P., Ranke M. B. et al. 1998 Paternally inherited deletion of CSH1 in a patient with Silver-Russell syndrome. J. Med. Genet. 35, 784-786.
15. Eggermann T., Schonherr N., Eggermann K. and Wollmann H. 2007 Hypomethylation in the 11p15 telomeric imprinting domain in a patient with Silver-Russell syndrome with a CSH1 deletion (17q24) renders a functional role of this alteration unlikely. J. Med. Genet. 44, 77.
16. Eggermann T., Eggermann K. and Schönherr N. 2008 Growth retardation versus overgrowth: Silver-Russell syndrome is genetically opposite to Beckwith-Wiedemann syndrome. Trends Genet. 24, 195-204.
17. GH Research Society 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society. J. Clin. Endocrinol. Metab. 85, 3990-3993.
18. Gicquel C., Rossignol S., Cabrol S., Houang M., Steunou V., Barbu V. et al. 2005 Epimutation of the telomeric imprinting centre region on chromosome 11p15 in Silver-Russell syndrome. Nat. Genet. 37, 1003-1007.
19. Hall J. G. 1978 Microphallus, growth hormone deficiency, and hypoglycaemia in Russell-Silver syndrome. Am. J. Dis. Child. 132, 1149.
20. Hitchins M. P., Stanier P., Preece M. A. and Moore G. E. 2001 Silver-Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions. J. Med. Genet. 38, 810-819.
21. Monk D., Wakeling E. L., Proud V., Hitchins M., Abu-Amero S. N., Stanier P. et al. 2000 Duplication of 7p11. 2-p13, including GRB10, in Silver-Russell syndrome. Am. J. Hum. Genet. 66, 36-46.
22. Netchine I., Rossignol S., Dufourg M. N., Azzi S., Rousseau A., Perin L. et al. 2007 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigeneticphenotypic correlations. J. Clin. Endocr. Metab. 92, 3148-3154.
23. Nishi Y., Nakanishi Y., Kawaguchi S. and Usui T. 1982 Russel-Silver syndrome and growth hormone deficiency. Acta Pediatr. Scand. 71, 1035-1036.
24. O'Brien J., Sadeghi-Nejad A. and Feingold M. 1978 Growth hormone deficiency in a patient with Silver-Russel syndrome. J. Pediatr. 93, 151-152.
25. Price S. M., Stanhope R., Garrett C., Preece M. A. and Trembath R. C. 1999 The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria. J. Med. Genet. 36, 837-842.
26. Rakover Y., Dietsch S., Ambler G. R., Chock C., Thomsett M. and Cowell C. T. 1996 Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand growth database (OZGROW). Eur. J. Pediatr. 155, 851-857.
27. Ranke M. B. and Lindberg A. 1996 Growth hormone treatment of short children born small for gestational age or with Silver-Russel syndrome: results from KIGS (Kabi international growth study), including the first report on final height. Acta Paediatr. Suppl. 417, 18-26.
28. Rochiccioli P., Tauber M., Moisan W. and Pienkowski C. 1989 Investigation of growth hormone secretion in patients with intrauterine growth retardation. Acta. Pediatr. Scand. Suppl. 349, 42-46.
29. Rossignol S., Netchine I., Le Bouc Y. and Gicquel C. 2008 Epigenetics in Silver-Russel syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 22, 403-414.
30. Schonherr N., Meyer E., Roos A., Schmidt A., Wollmann H. A. and Eggermann T. 2007 The centromeric 11p15 imprinting centre is also involved in Silver-Russell syndrome. J. Med. Genet. 44, 59-63.
31. Stanhope R., Albanese A. and Azcona C. 1989 Growth hormone treatment of Russell-Silver syndrome. Acta Paediatr. Scand. Suppl. 349, 35-41.
32. Stanhope R., Albanese A. and Azcona C. 1998 Growth hormone treatment of Russell-Silver syndrome. Horm. Res. 49, 37-40.
33. Stogmann W., Borkenstein M. and Grubbauer H. M. 1978 Silver-Russel syndrom mit panhypopituitarismus. Klin. Pediatr. 190, 586-590.
34. Takai D., Gonzales F. A., Tsai Y. C., Thayer M. J. and Jones P. A. 2001 Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum. Mol. Genet. 10, 2619-2626.
35. Tanner J. M. and Ham T. J. 1969 Low birth weight dwarfism with asymmetry (Silver's syndrome): treatment with human growth hormone. Arch. Dis. Child. 44, 231-243.
36. Tanner J. M., Lejarraga H. and Cameron N. 1975 The natural history of the Silver-Russell syndrome: a longitudinal study of thirty-nine cases. Pediatr. Res. 9, 611-623.
37. Theintz G., Lopez A. L., Schorderet D. and Sizonenko P. C. 1989 Growth in a case of Russell-Silver syndrome treated for hypopituitarism. Helv. Pediatr. Acta 43, 325-331.
38. WHO Multicentre Growth Reference Study Group 2006 WHO child growth standards based on length, height, weight and age. Acta Paediatr. Suppl. 450, 76-85.
39. Wilson A. T., Rose S. R., Cohen P., Rogol A. D., Backeljauw P., Brown R. et al. 2003 Update of guidelines for the use of growth hormone in children: The Lawson Wilkins pediatric endocrinology society drug and therapeutics committee. J. Pediatr. 143, 415-421.
40. Wollmann H. A., Kirchner T., Enders H., Preece M. A. and Ranke M. B. 1995 Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur. J. Pediatr. 154, 958-968.
41. Yamazawa K., Kagami M., Nagai T., Kondoh T., Onigata K., Maeyama K. et al. 2008 Molecular and clinical findings and their correlations in Silver-Russell syndrome: implications for a positive role of IGF2 in growth determination and differential imprinting regulation of the IGF2-H19 domain in bodies and placentas. J. Mol. Med. 86, 1171-1181.